Additionally, their derived exosomes have been shown to inhibit inflammation in osteoarthritis through the HMGB1/TLR4/NF-κB pathway, a promising avenue for therapeutic intervention in KOA (55). The gene discussed is TLR4; the disease is osteoarthritis.